Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 23Neoplasm Metastasis 9Squamous Cell Carcinoma of Head and Neck 3Triple Negative Breast Neoplasms 2Recurrence 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Melanoma 2Lymphangioma 2Hyperglycemia 2Head and Neck Squamous Cell Cancer 2Vascular Malformations 1Uveal Melanoma 1Stomach Neoplasms 1Solid Tumor 1Skin Diseases, Vascular 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Oropharyngeal Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Meningioma 1Lymphatic Abnormalities 1Lymphangioma, Cystic 1Hormone Receptor Positive Breast Carcinoma 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Exanthema 1

Interventions

Paclitaxel 11Carboplatin 8Radiotherapy 6Cyclophosphamide 6Trastuzumab 5Chemotherapy, Adjuvant 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4Epirubicin 3Doxorubicin 3Cryosurgery 3Cisplatin 3pertuzumab 2Surgical Procedures, Operative 2Radiotherapy, Conformal 2Radiation 2Letrozole 2Lapatinib 2Cryotherapy 2Brachytherapy 2talimogene laherparepvec 1sargramostim 1ferric carboxymaltose 1atezolizumab 1aldesleukin 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Zoledronic Acid 1Vorinostat 1VPS Coriolus versicolor extract 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Ductal, Breast × Alpelisib × Clear all
NCT01791478 2024-07-23

BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

Vanderbilt-Ingram Cancer Center

Phase 1 Active not recruiting
46 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡